Search: onr:"swepub:oai:DiVA.org:umu-127482" >
Points for Consider...
Points for Consideration for dengue vaccine introduction : recommendations by the Dengue Vaccine Initiative
-
Lim, Jacqueline Kyungah (author)
-
Lee, Yong-Seok (author)
-
Wilder-Smith, Annelies (author)
-
show more...
-
Thiry, Georges (author)
-
Mahoney, Richard (author)
-
Yoon, In-Kyu (author)
-
show less...
- 2016-01-06
- 2016
- English.
-
In: Expert Review of Vaccines. - : Informa UK Limited. - 1476-0584 .- 1744-8395. ; 15:4, s. 529-538
- Related links:
-
https://urn.kb.se/re...
-
show more...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- Dengue is a public health problem in the tropics and subtropics. There are several vaccine candidates in clinical development. However, there may be gaps in the new vaccine introduction after vaccine licensure before it becomes available in developing countries. In anticipation of the first dengue vaccine candidate to be licensed, Dengue Vaccine Initiative (DVI) and, its predecessor, Pediatric Dengue Vaccine Initiative (PDVI) have been working on points for consideration to accelerate evidence-based dengue vaccine introduction, once a vaccine becomes available. In this paper, we review the history of PDVI and its successor, the DVI, and elaborate on the points of consideration for dengue vaccine introduction.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Hälsovetenskap -- Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Health Sciences -- Public Health, Global Health, Social Medicine and Epidemiology (hsv//eng)
Keyword
- Dengue
- vaccine
- introduction
- Dengue Vaccine Initiative
- points for consideration
Publication and Content Type
- ref (subject category)
- for (subject category)
Find in a library
To the university's database